TMCnet News

Research and Markets: Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market - Global Forecasts to 2017
[February 07, 2013]

Research and Markets: Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market - Global Forecasts to 2017


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/vz5l5c/cardiac) has announced the addition of the "Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts to 2017" report to their offering.

The cardiac monitoring and cardiac rhythm management devices market is divided into two segments, namely,conventional monitoring devices and cardiac rhythm management (CRM) devices; the market is forecast till 2017.Over the years,these devices have evolved greatly from traditional monitoring devices to smaller ones with enhancedutility, sensitivity, automation, and performance.

The global cardiac monitoring and cardiac rhythm management market was worth $18.4 billion in the year 2012. Increasing incidence of cardiovascular diseases, technological advancement, rising cost of cardiac disease treatment, and government regulations in favor of cardiac monitoringare is accelerating the growth of conventional monitors as well as CRM devices. However, the economic slowdown and unstable reimbursement policies will hamper the growth of this market, to a certain exten.



The CRM devices market faced certain challenges in the recent past, owing to research studies published in the Journal of the American Medical Association (JAMA) and hospital investigations conducted by the Department of Justice (DOJ), which reported the inappropriate use of these devices. This affected the sales of CRM devices. The defibrillators and pacemakers markets showed flat growth rates in the U.S. from 2009 to 2011. However, with the technological advancements such as introduction of MRI pacemakers, subcutaneous ICDs, and home automated external defibrillators(AEDs), this market is expected to bounce back.

The geographies covered in this study are North America, Europe, Asia and Rest of the world (RoW). These four regions are further segmented by major countries and geographic split for all the sub-segments is presented at the regional level. North America is the largest market for cardiac monitoring and cardiac rhythm management, followed by Europe and Asia. North America and Europe is expected to grow at a slower pace primarily due to the economic slowdown and market maturity. The Asian market, especially India and China, is expected to witness a boost in demand for cardiac monitoring and CRM products and is poised to register maximum growth over the next five years, owing to the rising incidence of cardiovascular diseases and increased purchasing power of patients.


Key Topics Covered:

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

4 GLOBAL CONVENTIONAL CARDIAC MONITORING DEVICES MARKET

5 GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET

6 GLOBAL CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END-USERS

7 GEOGRAPHIC ANALYSIS

8 COMPETITIVE LANDSCAPE

9 COMPANY PROFILES

Companies Mentioned

- BIOTRONIK SE & CO. KG

- BOSTON SCIENTIFIC CORPORATION

- CARDIAC SCIENCE CORPORATION

- CARDIONET, INC.

- ECARDIO DIAGNOSTCIS, LLC

- GE HEALTHCARE (DIVISION OF GENERAL ELECTRIC COMPANY)

- LIFEWATCH AG

- MEDTRONIC, INC.

- MIDMARK CORPORATION

- MORTARA INSTRUMENT, INC.

- NIHON KOHDEN CORPORATION

- SPACELABS HEALTHCARE

- PHILIPS HEALTHCARE

- SCHILLER AG

- SCOTTCARE CORPORATION

- SORIN S.P.A

- ST. JUDE MEDICAL, INC.

- WELCH ALLYN, INC.

- ZOLL MEDICAL CORPORATION

For more information visit http://www.researchandmarkets.com/research/vz5l5c/cardiac


[ Back To TMCnet.com's Homepage ]